Related content

Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer

By Havrilesky L.J.   Alvarez A.A.   Sayer R.A.   Lancaster J.M.   Soper J.T.   Berchuck A.   Clarke-Pearson D.L.   Rodriguez G.C.   Carney M.E.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 51-57

Academic Press

Access to resources Recommend Favorite

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

By Rein D.T.   Kurbacher C.M.   Breidenbach M.   Schöndorf T.   Schmidt T.   König E.       Mallmann P.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 98-103

Academic Press

Access to resources Recommend Favorite

Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan

By Kobayashi Michiya   Oba Koji   Sakamoto Junichi   Kondo Ken   Nagata Naoki   Okabayashi Takehiro   Namikawa Tsutomu   Hanazaki Kazuhiro  

Gastric Cancer, Vol. 10, Iss. 1, 2007-02 ,pp. : 52-57

Springer Publishing Company

Access to resources Recommend Favorite

Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin

By Ueda Yutaka   Miyake Takahito   Egawa-Takata Tomomi   Miyatake Takashi   Matsuzaki Shinya   Yokoyama Takuhei   Yoshino Kiyoshi   Fujita Masami   Enomoto Takayuki   Kimura Tadashi  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 829-835

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 99-100

Informa Healthcare

Access to resources Recommend Favorite